Navigation Links
Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
Date:2/5/2013

NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTC:ORMPD) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Nadav Kidron , Chief Executive Officer & Director, will present at RetailInvestorConferences.com.

DATE:     February 7, 2013

TIME:      9:15 AM EST

LINK:      www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching FDA-approved Phase 2 clinical trials, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 1b/2a trials. The company's corporate and R&D headquarters are based in Jerusalem.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
4. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
9. Icahn Issues Statement Regarding Amylin Pharmaceuticals
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 ... therapeutic market research report of 68 pages with ... business intelligence library. The report "Pemphigus - Pipeline ... the therapeutic development for Pemphigus , complete ... by drug target, mechanism of action (MoA), route ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)... TUCSON, Ariz. , March 31, 2015  SynCardia ... Investigational Device Exemption (IDE) clinical study on the effective ... The ... with as many as 30 heart failure patients. Patients ... Total Artificial Heart as a bridge to a donor ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
... BRIGHTON, Mich., March 15, 2012 LifeSecure Insurance ... one-stop online shop where caregivers can access quality home ... needs of loved ones. LifeSecure,s Caregiver,s ... daily living aids and home modification tools to medical ...
... 15, 2012 Heptares Therapeutics, the leading GPCR ... Kenny, will present overview of the Company at 09:45am CET ... Annual BIO-Europe Spring international partnering conference. The presentation will take ... which is produced by EBD Group, is taking place at ...
Cached Medicine Technology:LifeSecure Opens Online Caregiver's Marketplace 2Heptares to Present at 6th Annual BIO-Europe Spring Conference on 20 March 2012 2
(Date:4/1/2015)... Natural fertility experts from around the world will ... Integrative Fertility Symposium ( https://ifsymposium.com/ ) April 30th to ... 515 West Hastings Street, Vancouver BC. There will also ... pm to 5:00 pm at Harbour Centre. , "The ... in the world to bring together reproductive endocrinologists, urologists, ...
(Date:4/1/2015)... Raleigh, NC (PRWEB) April 01, 2015 ... treatment option available to them, thanks to the FDA’s ... here to read the full story on the ... vaccine made from a modified version of the bacteria ... agreed to give its manufacturer grant funding and other ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 Eighty ... in athletics grants from California Casualty . Many ... or reduced-cost lunches and subsequently have fewer and fewer ... named after California Casualty Chairman Emeritus Thomas R. Brown, ... translated to the classroom. Since its inception in ...
(Date:4/1/2015)... North Carolina (PRWEB) April 01, 2015 ... and assisted living placement counseling, recently opened a new office ... Amada franchise partners Tracy and Lee Bissett decided to make ... rights to the area after over 20 years of experience ... on Thursday, April 2nd. , When asked what ...
(Date:4/1/2015)... On April 1st, 2015, Dr. Jason Helfrich, co-founder of 100% ... discuss the epidemic known as “Text Neck.” The average human head ... which it is bent forward, such as when bent to look ... cause poor posture often times leading to wear and tear of ... on their cell phone device emailing, keeping up with social media ...
Breaking Medicine News(10 mins):Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 3Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5Health News:Amada Senior Care Expands to Eastern North Carolina 2Health News:Dr. Jason Helfrich, Co-Founder of 100% Chiropractic, is a Guest on Better TV to Discuss “Text Neck” 2
... one day lead to new targets, treatments, researcher says , ... have spotted two new regions of the human genome that ... The findings, published in the June issue of the ... patients or people at risk for the devastating dementia just ...
... 2010 Researchers at the Translational Genomics Research Institute ... Virginia G. Piper Cancer Center at Scottsdale Healthcare have ... of patients with an aggressive type of lung cancer. ... which patients with small cell lung cancer are resistant ...
... CA (June 14, 2010) Apple juice can be a useful ... the normal progression of moderate-to-severe Alzheimer,s Disease (AD), according to ... Other Dementias (AJADD), published by SAGE. In the ... of apple juice a day for a month, their caregivers ...
... HOUSTON - Margaret M. Fields, an advanced practice nurse ... Department of Gynecologic Oncology, is the recipient of the ... by The Brown Foundation, Inc. A committee of ... staff reviewed nominations from peers and patients before selecting ...
... ... on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen’s Prolia is the newest ... every 6 months via injection. , ... (Vocus) June 14, 2010 -- According to a recent analysis by SDI , ...
... describes the current state of the science in combating ... In his article in the June 10, 2010 ... Neuroblastoma," Maris reviews the field,s latest research knowledgemuch of ... at The Children,s Hospital of Philadelphia. Maris directs a ...
Cached Medicine News:Health News:Scientists Spot More Genes Related to Alzheimer's 2Health News:TGen-VARI-SHC research helps predict success with cancer drugs 2Health News:TGen-VARI-SHC research helps predict success with cancer drugs 3Health News:Peg Fields to receive MD Anderson's highest nurse-oncologist honor 2Health News:Peg Fields to receive MD Anderson's highest nurse-oncologist honor 3Health News:SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option 2Health News:Internationally known neuroblastoma expert reviews progress versus challenging childhood cancer 2
... trocar has a sharp linear blade and a ... VERSAPORT™ PLUS V2 trocar is available in 5 ... 5 mm-12 mm long sizes with a radiolucent ... has a sharp linear blade and a spring-loaded ...
The Auto Suture™ Woodford Spike™ Trocar and Cannula is a sterile, single-use device designed for primary punctures during laparoscopy. Dexide refers to a separate offering of trocars from...
... of Surgical Access ...unlike any trocar system ... system is actually four systems in one ... and clinically adaptive to all of your ... and bladed or dilating tip styles, OnePort™ ...
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
Medicine Products: